Concepedia

Aileen Höhne

AH

Statistics

Publications

5

Citations

397

H-Index

5

Active since

2004

Affiliations

ETH Zurich(Current)

Bayer (Germany)

Aileen Höhne is an author at ETH Zurich specializing in molecular imaging, radiopharmaceutical design, and medicine.

Publications per year

2004–2017

5

Publications

5

Synthesis, <sup>18</sup>F-Labeling, and <i>in Vitro</i> and <i>in Vivo</i> Studies of Bombesin Peptides Modified with Silicon-Based Building Blocks

Aileen Höhne, Linjing Mu, Michael Honer et al. · Bioconjugate Chemistry · 2008 · 123 citations

Medicine, Nuclear Medicine, Pharmacology +17

Silicon‐Based Building Blocks for One‐Step <sup>18</sup>F‐Radiolabeling of Peptides for PET Imaging

Linjing Mu, Aileen Höhne, P. August Schubiger et al. · Angewandte Chemie International Edition · 2008 · 110 citations · Full text

Medicine, Nuclear Medicine, Radiology +16

Organofluorosilanes as Model Compounds for <sup>18</sup>F‐Labeled Silicon‐Based PET Tracers and their Hydrolytic Stability: Experimental Data and Theoretical Calculations (PET=Positron Emission Tomography)

Aileen Höhne, Lian Yu, Linjing Mu et al. · Chemistry - A European Journal · 2009 · 57 citations

Natural Sciences, Chemistry, Nuclear Medicine +15

Synthesis of<sup>18</sup>F-labelled cyclooxygenase-2 (COX-2) inhibitors via Stille reaction with 4-[<sup>18</sup>F]fluoroiodobenzene as radiotracers for positron emission tomography (PET)

F. Wüst, Aileen Höhne, Peter Metz · Organic & Biomolecular Chemistry · 2004 · 55 citations

Medicine, Medicinal Chemistry, Pharmacology +17

Proof of Therapeutic Efficacy of a<sup>177</sup>Lu-Labeled Neurotensin Receptor 1 Antagonist in a Colon Carcinoma Xenograft Model

Jörg Schulz, Martin Rohracker, Marvin Stiebler et al. · Journal of Nuclear Medicine · 2017 · 52 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 5